Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Other Working Capital Changes: 2021-2025

Historic Other Working Capital Changes for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$220,000.

  • Biofrontera's Other Working Capital Changes rose 95.44% to -$220,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.1 million, marking a year-over-year decrease of 1191.20%. This contributed to the annual value of -$5.2 million for FY2024, which is 200.00% down from last year.
  • Per Biofrontera's latest filing, its Other Working Capital Changes stood at -$220,000 for Q3 2025, which was down 130.18% from $729,000 recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Other Working Capital Changes peaked at $5.5 million during Q4 2023, and registered a low of -$4.8 million during Q3 2024.
  • For the 3-year period, Biofrontera's Other Working Capital Changes averaged around $73,300, with its median value being -$167,000 (2024).
  • In the last 5 years, Biofrontera's Other Working Capital Changes crashed by 4,454.22% in 2022 and then surged by 16,869.70% in 2023.
  • Quarterly analysis of 5 years shows Biofrontera's Other Working Capital Changes stood at $4.0 million in 2021, then tumbled by 100.82% to -$33,000 in 2022, then surged by 16,869.70% to $5.5 million in 2023, then plummeted by 612.70% to -$4.8 million in 2024, then soared by 95.44% to -$220,000 in 2025.
  • Its Other Working Capital Changes stands at -$220,000 for Q3 2025, versus $729,000 for Q2 2025 and $224,000 for Q1 2025.